Summary
Definition
History and exam
Key diagnostic factors
- history of soil exposure in an endemic area
- infection with other parasites
Other diagnostic factors
- abdominal pain
- altered bowel habit
- weight loss
- fever (hyperinfection)
- signs of sepsis (hyperinfection)
- chronic cough
- wheezing
- pruritus or dermatitis
- larva currens
- urticaria
- cutaneous larva migrans
- apparent drug reaction rash (hyperinfection)
- other skin complaints
- symptoms and signs of inflammatory bowel disease
Risk factors
- soil exposure in or migrants from an endemic area of the world
- international travelers
- corticosteroids (risk of hyperinfection)
- human T-cell lymphotropic virus type-1 (HTLV-1) infection (risk of hyperinfection)
- impaired immunity
- solid-organ transplant recipient
Diagnostic investigations
1st investigations to order
- stool ova and parasites (O&P) exam
- CBC with differential
- therapeutic trial with ivermectin (in specific situations)
Investigations to consider
- sputum O&P exam
- clinical sample (nonstool or sputum) O&P exam
- strongyloides IgG serology
- tissue biopsy
Emerging tests
- polymerase chain reaction (PCR)
Algoritmo de tratamento
immigrant from endemic area
able to tolerate oral therapy: not critically ill (nonpregnant)
unable to tolerate oral therapy or critically ill (nonpregnant)
pregnant
poor clinical response or initial treatment not completed
Colaboradores
Autores
David R. Boulware, MD, MPH, CTropMed

Professor of Medicine
Department of Medicine
University of Minnesota
Minneapolis
MN
Declarações
DRB is an author of a number of references cited in this topic.
Revisores
Elizabeth Barnett, MD
Professor
Department of Pediatrics
Boston Medical Center
Boston University
Boston
MA
Declarações
EB declares that she is on a speaker's bureau for Merck. She is an author of a reference cited in this topic.
Linda Nield, MD, FAAP
Professor of Pediatrics
West Virginia University School of Medicine
Morgantown
WV
Declarações
LN is an author of a reference cited in this topic.
Geoff Gill, MA, MSc, MD, FRCP, DTMH
Professor of International Medicine and Honorary Consultant Physician
Liverpool School of Tropical Medicine
Liverpool
UK
Declarações
GG declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
World Gastroenterology Organisation. WGO practice guideline: management of strongyloidiasis. February 2018 [internet publication].Texto completo
Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002 Jun;66(6):749-52. Resumo
Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Hookworm
- Schistosomiasis
- Filariasis
Mais Diagnósticos diferenciaisGuidelines
- Strongyloidiasis: resources for health professionals
- CDC Yellow Book: health information for international travel - strongyloidiasis
Mais DiretrizesPatient information
Pinworm
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer